121 related articles for article (PubMed ID: 30369339)
1. Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.
Barandiaran M; Moreno F; de Arriba M; Indakoetxea B; Boda I; Gabilondo A; Tainta M; López de Munain A
J Int Neuropsychol Soc; 2019 Jan; 25(1):39-47. PubMed ID: 30369339
[TBL] [Abstract][Full Text] [Related]
2. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia.
Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC
Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia.
Jiskoot LC; Panman JL; van Asseldonk L; Franzen S; Meeter LHH; Donker Kaat L; van der Ende EL; Dopper EGP; Timman R; van Minkelen R; van Swieten JC; van den Berg E; Papma JM
J Neurol; 2018 Jun; 265(6):1381-1392. PubMed ID: 29627938
[TBL] [Abstract][Full Text] [Related]
5. Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers.
Lee SE; Sias AC; Kosik EL; Flagan TM; Deng J; Chu SA; Brown JA; Vidovszky AA; Ramos EM; Gorno-Tempini ML; Karydas AM; Coppola G; Geschwind DH; Rademakers R; Boeve BF; Boxer AL; Rosen HJ; Miller BL; Seeley WW
Neuroimage Clin; 2019; 22():101751. PubMed ID: 30921613
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic cognitive decline in familial frontotemporal dementia: A longitudinal study.
Jiskoot LC; Dopper EG; Heijer Td; Timman R; van Minkelen R; van Swieten JC; Papma JM
Neurology; 2016 Jul; 87(4):384-91. PubMed ID: 27358337
[TBL] [Abstract][Full Text] [Related]
7. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
[TBL] [Abstract][Full Text] [Related]
8. Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience.
Sellami L; Rucheton B; Ben Younes I; Camuzat A; Saracino D; Rinaldi D; Epelbaum S; Azuar C; Levy R; Auriacombe S; Hannequin D; Pariente J; Barbier M; Boutoleau-Bretonnière C; Couratier P; Pasquier F; Deramecourt V; Sauvée M; Sarazin M; Lagarde J; Roué-Jagot C; Forlani S; Jornea L; David I; ; ; LeGuern E; Dubois B; Brice A; Clot F; Lamari F; Le Ber I
Neurobiol Aging; 2020 Jul; 91():167.e1-167.e9. PubMed ID: 32171590
[TBL] [Abstract][Full Text] [Related]
9. Modelling the cascade of biomarker changes in
Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; Meeter LHH; Donker Kaat L; Rombouts SARB; Vernooij MW; Kievit AJA; Premi E; Cosseddu M; Bonomi E; Olives J; Rohrer JD; Sánchez-Valle R; Borroni B; Bron EE; Van Swieten JC; Papma JM; Klein S;
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):494-501. PubMed ID: 33452053
[TBL] [Abstract][Full Text] [Related]
10. Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms.
Huin V; Barbier M; Bottani A; Lobrinus JA; Clot F; Lamari F; Chat L; Rucheton B; Fluchère F; Auvin S; Myers P; Gelot A; Camuzat A; Caillaud C; Jornéa L; Forlani S; Saracino D; Duyckaerts C; Brice A; Durr A; Le Ber I
Brain; 2020 Jan; 143(1):303-319. PubMed ID: 31855245
[TBL] [Abstract][Full Text] [Related]
11. A multimodal MRI-based classification signature emerges just prior to symptom onset in frontotemporal dementia mutation carriers.
Feis RA; Bouts MJRJ; de Vos F; Schouten TM; Panman JL; Jiskoot LC; Dopper EGP; van der Grond J; van Swieten JC; Rombouts SARB
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1207-1214. PubMed ID: 31203211
[TBL] [Abstract][Full Text] [Related]
12. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration.
Tavares TP; Mitchell DGV; Coleman KK; Coleman BL; Shoesmith CL; Butler CR; Santana I; Danek A; Gerhard A; de Mendonca A; Borroni B; Tartaglia MC; Graff C; Galimberti D; Tagliavini F; Moreno F; Frisoni G; Rowe JB; Levin J; Van Swieten JC; Otto M; Synofzik M; Sanchez-Valle R; Vandenberghe R; Laforce RJ; Ghidoni R; Sorbi S; Ducharme S; Masellis M; Rohrer J; Finger E;
J Neurol Neurosurg Psychiatry; 2020 Sep; 91(9):975-984. PubMed ID: 32769115
[TBL] [Abstract][Full Text] [Related]
13. Decreased Prefrontal Activation during Matrix Reasoning in Predementia Progranulin Mutation Carriers.
Alexander C; Zeithamova D; Hsiung GR; Mackenzie IR; Jacova C
J Alzheimers Dis; 2018; 62(2):583-589. PubMed ID: 29480174
[TBL] [Abstract][Full Text] [Related]
14. Autosomal Dominant Frontotemporal Lobar Degeneration in a Filipino Family with Progranulin Mutation.
Dominguez J; Ng A; Yu J; Guevarra AC; Daroy ML; Alfon A; Catindig JA; Dizon M; Santiago J; Del Moral MC; Yu J; Jamerlan A; Ligsay A; Bagyinszky E; An SS; Kim S
Dement Geriatr Cogn Disord; 2020; 49(6):557-564. PubMed ID: 33486486
[TBL] [Abstract][Full Text] [Related]
15. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Khrouf W; Saracino D; Rucheton B; Houot M; Clot F; Rinaldi D; Vitor J; Huynh M; Heng E; Schlemmer D; Pasquier F; Deramecourt V; Auriacombe S; Azuar C; Levy R; Bombois S; Boutoleau-Brétonnière C; Pariente J; Didic M; Wallon D; Fluchère F; Auvin S; Younes IB; ; ; Nadjar Y; Brice A; Dubois B; Bonnefont-Rousselot D; Le Ber I; Lamari F
Neurobiol Dis; 2023 Jun; 181():106108. PubMed ID: 37003407
[TBL] [Abstract][Full Text] [Related]
16. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study.
Panman JL; Jiskoot LC; Bouts MJRJ; Meeter LHH; van der Ende EL; Poos JM; Feis RA; Kievit AJA; van Minkelen R; Dopper EGP; Rombouts SARB; van Swieten JC; Papma JM
Neurobiol Aging; 2019 Apr; 76():115-124. PubMed ID: 30711674
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia.
Benussi A; Gazzina S; Premi E; Cosseddu M; Archetti S; Dell'Era V; Cantoni V; Cotelli MS; Alberici A; Micheli A; Benussi L; Ghidoni R; Padovani A; Borroni B
Neurobiol Aging; 2019 Apr; 76():133-140. PubMed ID: 30711676
[TBL] [Abstract][Full Text] [Related]
18. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
[TBL] [Abstract][Full Text] [Related]
19. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
[TBL] [Abstract][Full Text] [Related]
20. Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.
Chen Q; Boeve BF; Senjem M; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Graff-Radford J; Graff-Radford N; Jack CR; Jones D; Knopman D; Kremers WK; Lapid M; Rademakers R; Ramos EM; Syrjanen J; Boxer AL; Rosen H; Wszolek ZK; Kantarci K
Neurobiol Aging; 2020 Apr; 88():42-50. PubMed ID: 31918955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
